Dayton Misfeldt

Dayton Misfeldt is a declared insider of Viracta Therapeutics, Inc., with filings sourced from SEC (Form 4). In total, 26 filings cover trades dated from 30 June 2010 to 27 October 2017.

Both buying and selling appear: 6 purchases worth €7.3M, against 14 sales worth €7.5M. Taken together, the sales exceed the purchases by €240k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 4 share grants. In 2017 alone, the filings show 2 purchases and no sales.

Half of the purchases are above €386k and half below.

The record was last updated on 30 October 2017 with an open-market purchase (€675k) in Viracta Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.